Abiraterone Acetate

規格

154229-18-2CAS番号

620-314-7EC番号

[(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-pyridin-3-yl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetateIUPAC名

C26H33NO2化学式

391.5 g/mol分子量

Abiraterone acetate; 154229-18-2; Zytiga; CB7630; CB-7630; Yonsa; DTXSID3049043; EM5OCB9YJ6; 17-(3-Pyridyl)-5,16-androstadien-3beta-acetate; NSC-748121; NSC-749227; 17-(pyridin-3-yl)androsta-5,16-dien-3beta-yl acetate; JNJ-212082; DTXCID4028969; CHEBI:68639; AKEEGA COMPONENT ABIRATERONE ACETATE; Androsta-5,16-dien-3-ol, 17-(3-pyridinyl)-, acetate (ester), (3beta)-; ABIRTEGA; RefChem:57134; BR9004; BR9004-1; CB 7630; (3S,8R,9S,10R,13S,14S)-10,13-DIMETHYL-17-(PYRIDIN-3-YL)-2,3,4,7,8,9,10,11,12,13,14,15-DODECAHYDRO-1H-CYCLOPENTA[A]PHENANTHREN-3-YL ACETATE; Abiraterone acetate [USAN]; 3-Epiabiraterone Acetate; [(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-pyridin-3-yl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate; Abiraterone acetate (Standard); (3beta)-17-(pyridin-3-yl)androsta-5,16-dien-3-yl acetate; 17-(3-Pyridyl)androsta-5, acetate; Androsta-5, 17-(3-pyridinyl)-, 3-acetate,; UNII-EM5OCB9YJ6; Abirapro; Abiratas;; Abretone;; Zytiga;; abiraterone-acetate; NCGC00186462-01; 3S,9S,10R,13S,14S)-10,13-dimethyl-17-pyridin-3-yl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-ol, 3-acetate; Abiraterone acetate; CB 7630; Zytiga; (3beta)-17-(3-Pyridinyl)-androsta-5,16-dien-3-ol Acetate (Ester); (3beta)-17-(3-Pyridinyl)androsta-5,16-dien-3-yl acetate; Abiraterone Acetate; Abiraterone Acotate; Zytiga (TN); 17-(pyridin-3-yl)androsta-5,16-dien-3-yl acetate; SCHEMBL93715; MLS006010090; CHEMBL271227; GTPL9288; orb1300972; Abiraterone acetate (JAN/USP); ABIRATERONE (AS ACETATE); ABIRATERONE ACETATE [MI]; SCHEMBL29353106; ABIRATERONE ACETATE [JAN]; EX-A107; UVIQSJCZCSLXRZ-UBUQANBQSA-N; GLXC-07201; ABIRATERONE ACETATE [VANDF]; ABIRATERONE ACETATE [MART.]; Tox21_113589; ABIRATERONE ACETATE [USP-RS]; ABIRATERONE ACETATE [WHO-DD]; BDBM50407398; EBC-23629; HY-75054R; NSC748121; NSC749227; s2246; Abiraterone acetate, >=98% (HPLC); AKOS015896502; CS-0544; DS-2007; FA16106; JNJ 212082; NSC 748121; NSC 749227; Abiraterone acetate - Bio-X trade mark; JNJ-2012082; ABIRATERONE ACETATE [ORANGE BOOK]; NCGC00379022-06; (3aS,3bR,7S,9aR,9bS,11aS)-9a,11a-dimethyl-1-(pyridin-3-yl)-3H,3aH,3bH,4H,6H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-yl acetate; AC-25760; BA164133; BP-43622; HY-75054; SMR004701235; ABIRATERONE ACETATE [USP MONOGRAPH]; A2891; CAS-154229-18-2; CS-0694903; T6215; D09701; 3b-acetoxy-17-(3-pyridyl)androsta-5,16-diene; EN300-7479171; 17-(3-Pyridyl)-5,16-androstadien-3-b-acetate; F213789; 3beta-Acetoxy-17-(3-pyridyl)androsta-5,16-diene; BRD-K24048528-001-01-7; BRD-K24048528-001-02-5; Q27888393; (3S)-3-Acetoxy-17-(pyridin-3-yl)androsta-5,16-diene; 3beta-17-(3-Pyridyl)androsta-5,16-dien-3-ol Acetate; Z1741979782; Abiraterone acetate, United States Pharmacopeia (USP) Reference Standard; ANDROSTA-5,16-DIEN-3-OL, 17-(3-PYRIDINYL)-, ACETATE (ESTER), (3.BETA.)-; (1S,2R,5S,10R,11S,15S)-2,15-dimethyl-14-(pyridin-3-yl)tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-7,13-dien-5-yl acetate; [(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-(3-pyridyl)-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate; Abiraterone Acetate Micronized別名